Precision Optics (POCI) investor relations material

Business overview and strategy

• Vertically integrated optics company leveraging proprietary micro-optics and imaging technologies for healthcare and defense/aerospace sectors, offering services from concept to mass manufacture.

• Over 40 years of growth, with expansion into medical devices, defense, telecom, and recent acquisitions to broaden capabilities.

• Business model emphasizes early-stage collaboration with key clients, robust R&D pipeline, and maintaining IP through internal and customer-funded research.

• Focus on micro-optics, 3D imaging, and digital imaging, with a disciplined investment approach and facility expansion to support growth.

• Strategic acquisitions and the launch of the Unity Platform aim to accelerate development and commercialization of new products.

Key technologies and markets

• Specializes in millimeter-sized cameras and patented opto-mechanical/electronic systems for minimally invasive surgery and defense applications.

• One of few global providers of 3D endoscopes, supporting next-gen robotic surgery and advanced imaging systems.

• Expertise in digital imaging electronics, especially CMOS-based systems, with full system design capabilities for both single-use and reusable devices.

• Main markets include medical devices (e.g., neurosurgery, cardiology, urology, arthroscopy) and aerospace/defense (e.g., UAVs, satellite communications, directed energy weapons).

Financial performance and outlook

• Revenue grew from $4.0M in 2017 to $21.0M in 2024, with 2026 guidance of $26M–$28M.

• Gross margins have ranged from 24% to 40% over recent years.

• Adjusted EBITDA has fluctuated, with recent years showing negative values, but improvements are targeted.

• Balance sheet as of 12/31/2025 shows $881K in cash, $4.9M in receivables, $4.3M in inventory, and $9.3M in shareholder equity.